Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Statins Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Astrovastatin
  • 1.3.3 Fluvastatin
  • 1.3.4 Lovastatin
  • 1.3.5 Pravastatin
  • 1.3.6 Simvastatin
  • 1.3.7 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Statins Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Clinics
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Statins Market Size
  • 2.1.1 Global Statins Revenue 2014-2025
  • 2.1.2 Global Statins Sales 2014-2025
• 2.2 Statins Growth Rate by Regions
  • 2.2.1 Global Statins Sales by Regions 2014-2019
  • 2.2.2 Global Statins Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Statins Sales by Manufacturers
  • 3.1.1 Statins Sales by Manufacturers 2014-2019
  • 3.1.2 Statins Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Statins Revenue by Manufacturers (2014-2019)
  • 3.2.2 Statins Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Statins Market Concentration Ratio (CR5 and HHI)
• 3.3 Statins Price by Manufacturers
• 3.4 Key Manufacturers Statins Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Statins Market
• 3.6 Key Manufacturers Statins Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Astrovastatin Sales and Revenue (2014-2019)
  • 4.1.2 Fluvastatin Sales and Revenue (2014-2019)
  • 4.1.3 Lovastatin Sales and Revenue (2014-2019)
  • 4.1.4 Pravastatin Sales and Revenue (2014-2019)
  • 4.1.5 Simvastatin Sales and Revenue (2014-2019)
  • 4.1.6 Others Sales and Revenue (2014-2019)
• 4.2 Global Statins Sales Market Share by Type
• 4.3 Global Statins Revenue Market Share by Type
• 4.4 Statins Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Statins Sales by Application

6 United States

• 6.1 United States Statins Breakdown Data by Company
• 6.2 United States Statins Breakdown Data by Type
• 6.3 United States Statins Breakdown Data by Application

7 European Union

• 7.1 European Union Statins Breakdown Data by Company
• 7.2 European Union Statins Breakdown Data by Type
• 7.3 European Union Statins Breakdown Data by Application

8 China

• 8.1 China Statins Breakdown Data by Company
• 8.2 China Statins Breakdown Data by Type
• 8.3 China Statins Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Statins Breakdown Data by Company
• 9.2 Rest of World Statins Breakdown Data by Type
• 9.3 Rest of World Statins Breakdown Data by Application
• 9.4 Rest of World Statins Breakdown Data by Countries
  • 9.4.1 Rest of World Statins Sales by Countries
  • 9.4.2 Rest of World Statins Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AstraZeneca
  • 10.1.1 AstraZeneca Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Statins
  • 10.1.4 Statins Product Introduction
  • 10.1.5 AstraZeneca Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Statins
  • 10.2.4 Statins Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 GlaxoSmithKline
  • 10.3.1 GlaxoSmithKline Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Statins
  • 10.3.4 Statins Product Introduction
  • 10.3.5 GlaxoSmithKline Recent Development
• 10.4 Novartis International
  • 10.4.1 Novartis International Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Statins
  • 10.4.4 Statins Product Introduction
  • 10.4.5 Novartis International Recent Development
• 10.5 Merck
  • 10.5.1 Merck Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Statins
  • 10.5.4 Statins Product Introduction
  • 10.5.5 Merck Recent Development
• 10.6 Biocon
  • 10.6.1 Biocon Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Statins
  • 10.6.4 Statins Product Introduction
  • 10.6.5 Biocon Recent Development
• 10.7 Concord Biotech
  • 10.7.1 Concord Biotech Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Statins
  • 10.7.4 Statins Product Introduction
  • 10.7.5 Concord Biotech Recent Development
• 10.8 Aurobindo Pharma
  • 10.8.1 Aurobindo Pharma Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Statins
  • 10.8.4 Statins Product Introduction
  • 10.8.5 Aurobindo Pharma Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Statins Sales Channels
  • 11.2.2 Statins Distributors
• 11.3 Statins Customers

12 Market Forecast

• 12.1 Global Statins Sales and Revenue Forecast 2019-2025
• 12.2 Global Statins Sales Forecast by Type
• 12.3 Global Statins Sales Forecast by Application
• 12.4 Statins Forecast by Regions
  • 12.4.1 Global Statins Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Statins Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide.
In 2019, the market size of Statins is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Statins.

This report studies the global market size of Statins, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Statins sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma

Market Segment by Product Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others

Market Segment by Application
Hospitals
Clinics

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Statins status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Statins manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Statins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025